3 Hated Stocks Walking a Fine LineThe past year hasn't been kind to the stocks featured in this article.
Each has tumbled to their lowest points in 12 months, leaving investors to decide whether they're witnessing fire sales or falling knives.
Q4 Earnings Highlights: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty StocksQuarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at LeMaitre (
NASDAQ:LMAT) and the best and worst performers in the surgical equipment & consumables - specialty industry.
Spotting Winners: Teleflex (NYSE:TFX) And Surgical Equipment & Consumables - Specialty Stocks In Q4The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - specialty stocks fared in Q4, starting with Teleflex (
NYSE:TFX).
Winners And Losers Of Q4: Integra LifeSciences (NASDAQ:IART) Vs The Rest Of The Surgical Equipment & Consumables - Specialty StocksLooking back on surgical equipment & consumables - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Integra LifeSciences (
NASDAQ:IART) and its peers.
Q4 Earnings Review: Surgical Equipment & Consumables - Specialty Stocks Led by Intuitive Surgical (NASDAQ:ISRG)As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - specialty industry, including Intuitive Surgical (
NASDAQ:ISRG) and its peers.
Notice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your BehalfPHILADELPHIA, March 22, 2025 (GLOBE NEWSWIRE) -- Grabar Law Office is investigating whether the Board of Directors of Integra LifeSciences Holdings Corp. (
NASDAQ: IART) breached their fiduciary duties owed to the Company.
3 Value Stocks in the DoghouseThe low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer.
However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
3 Reasons IART is Risky and 1 Stock to Buy InsteadWhile the broader market has struggled with the S&P 500 down 1.3% since September 2024, Integra LifeSciences has surged ahead as its stock price has climbed by 31.6% to $22.79 per share. This performance may have investors wondering how to approach the situation.
3 Small-Cap Stocks in the DoghouseSmall-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings.
However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Teleflex Earnings: What To Look For From TFXMedical technology company Teleflex (
NYSE:TFX)
will be reporting earnings tomorrow before market open. Here’s what to look for.
What To Expect From LeMaitre’s (LMAT) Q4 EarningsMedical device company LeMaitre Vascular (
NASDAQ:LMAT)
will be announcing earnings results tomorrow after the bell. Here’s what to expect.
Why Is Integra LifeSciences (IART) Stock Rocketing Higher TodayShares of medical device company Integra LifeSciences (
NASDAQ:IART)
jumped 13.6% in the afternoon session after the company reported strong fourth quarter 2024 results that beat analysts' EPS and EBITDA expectations.
Integra LifeSciences (NASDAQ:IART) Misses Q4 Revenue EstimatesMedical device company Integra LifeSciences (
NASDAQ:IART) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 11.5% year on year to $442.6 million. Next quarter’s revenue guidance of $380 million underwhelmed, coming in 7.7% below analysts’ estimates. Its non-GAAP profit of $0.97 per share was 13.5% above analysts’ consensus estimates.
INTEGRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Integra LifeSciences Holdings Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmNEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Integra LifeSciences Holdings Corp. (
NASDAQ: IART) on behalf of long-term stockholders following a class action complaint that was filed against Integra on September 12, 2023 with a Class Period from March 11, 2019 to May 22, 2023. Our investigation concerns whether the board of directors of Integra have breached their fiduciary duties to the company.
